title: Effect of epigenetic histone modifications on E-cadherin splicing and expression in lung cancer.
abstract: We have identified an alternatively spliced, non-functional aberrant E-cadherin transcript that lacks exon 11 and is over expressed in malignant cells as compared to the normal non-malignant cells. This increase in the aberrant transcript is a mechanism of loss of E-cadherin gene expression as it is rapidly degraded by the nonsense mediated decay pathway. To study the mechanism of this gene missplicing we analyzed the role of histone epigenetic modifications in lung cancer cell lines. The treatment of low E-cadherin lung cancer cell lines with histone deacetylase inhibitor (HDACi, MS-275) resulted in the preferential expression of the correctly spliced transcripts in the low E-cadherin expressing cell lines only. Chromatin immunoprecipitation (ChIP) assays revealed that the histone hypoacetylation levels correlate with aberrant exon 11 splicing as there is more aberrant splicing in cell lines with E-cadherin promoter hypoacetylation. Inactivation of histone deacetylases (HDAC) 1, 2 and 3 resulted in an increase in E-cadherin expression and an increase in the ratio of the correctly spliced E-cadherin transcript. As transcription of the gene is closely linked to splicing, we considered the possibility that change in E-cadherin transcription correlates with splicing. The Zeb1 epithelial-mesenchymal transformation (EMT) inducer silences E-cadherin expression and could also alter the splicing of this exon. Inhibition of the E-cadherin promoter transcription with Zeb1 expression increases aberrant splicing and the reverse is observed when Zeb1 is knocked down. The role of HDAC inhibitors was also studied in vivo in a immunodeficient mouse xenograft model. Exposure of mice to HDACi resulted in growth inhibition, increase in E-cadherin expression, alteration of aberrant splicing and the reversal of EMT in mouse tumors. The findings support the modulation of E-cadherin exon 11 inclusion or exclusion by histone epigenetic modifications as they change the overall chromatin structure. The results provide an interesting link between epigenetic alterations in cancer cells and gene splicing in addition to their effect on gene silencing.
authors: UCLA West Los Angeles VA Medical Center, Division of Hematology Oncology Los Angeles, California.
authors: Wei
authors: W
authors: Liao
authors: Gwen
authors: G
authors: Jordaan
authors: Minu K
authors: MK
authors: Srivastava
authors: Steven
authors: S
authors: Dubinett
authors: Sherven
authors: S
authors: Sharma
authors: Sanjai
authors: S
authors: Sharma
keywords: E-cadherin; EMT; HDAC; HDAC inhibitor; Zeb1; histone modifications; splicing
references: Cancer Res. 2006 Jan 15;66(2):944-50
references: 16424029
references: Cancer Lett. 2010 Oct 28;296(2):216-24
references: 20452118
references: Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6975-80
references: 8692929
references: J Clin Oncol. 2009 Nov 10;27(32):5459-68
references: 19826124
references: Adv Biol Regul. 2012 Sep;52(3):377-88
references: 22884031
references: Differentiation. 1988 Jun;38(1):60-6
references: 2846394
references: Hum Mol Genet. 1999;8(10):1893-900
references: 10469842
references: BMC Genomics. 2012 Mar 29;13:123
references: 22455468
references: Nat Struct Mol Biol. 2009 Jun;16(6):670-6
references: 19448617
references: Cancer Cell. 2002 Jul;2(1):9-15
references: 12150820
references: J Thorac Oncol. 2009 Dec;4(12):1455-65
references: 20009910
references: Biochem Biophys Res Commun. 2006 May 19;343(4):995-1001
references: 16574063
references: Hum Mutat. 1996;8(1):8-18
references: 8807330
references: Cell. 2008 May 16;133(4):704-15
references: 18485877
references: Genes Dev. 2000 Jan 15;14(2):121-41
references: 10652267
references: Leukemia. 2010 Mar;24(3):660-3
references: 20016532
references: Nat Rev Cancer. 2007 Jun;7(6):415-28
references: 17508028
references: Nat Struct Mol Biol. 2007 Mar;14(3):185-93
references: 17310252
references: Lung Cancer. 1998 Nov;22(2):85-95
references: 10022216
references: Mol Cell Biol. 2004 Jan;24(1):306-19
references: 14673164
references: RNA. 2003 Aug;9(8):993-1006
references: 12869710
references: Cancer Cell Int. 2003 Oct 14;3(1):17
references: 14613514
references: Science. 2010 Feb 19;327(5968):996-1000
references: 20133523
references: BMC Genomics. 2010 Nov 25;11:669
references: 21108828
references: Annu Rev Biochem. 2003;72:291-336
references: 12626338
references: Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6066-71
references: 15447991
references: Oncogene. 2008 Nov 24;27(55):6920-9
references: 19029934
references: Cancer Sci. 2008 Apr;99(4):738-46
references: 18377425
references: Blood. 2009 Nov 5;114(19):4179-85
references: 19745069
references: Mol Cancer Ther. 2007 Jun;6(6):1683-91
references: 17541031
references: Mol Cancer Ther. 2009 Jun;8(6):1409-20
references: 19509247
references: Trends Biochem Sci. 2010 Sep;35(9):497-504
references: 20418102
references: Nat Struct Mol Biol. 2006 Jan;13(1):22-9
references: 16341228
references: Carcinogenesis. 1991 Sep;12(9):1627-31
references: 1654226
references: Nat Struct Mol Biol. 2009 Sep;16(9):990-5
references: 19684600
references: Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11456-60
references: 9326631
references: Cancer. 2007 Dec 15;110(12):2785-92
references: 17960794
references: Mol Cancer Ther. 2011 Sep;10(9):1751-9
references: 21764905
references: Nat Struct Mol Biol. 2006 Jan;13(1):5-7
references: 16395314
references: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4325-30
references: 19251664
references: Nat Rev Cancer. 2002 Jun;2(6):442-54
references: 12189386
references: Nucleic Acids Res. 2001 May 1;29(9):e45
references: 11328886
references: Genes Dev. 2010 Nov 1;24(21):2343-64
references: 21041405
references: Nature. 1997 Jan 23;385(6614):357-61
references: 9002523
references: PLoS One. 2011 Feb 02;6(2):e16727
references: 21311748
references: Mol Biol Cell. 2007 Nov;18(11):4615-24
references: 17855508
references: Mol Cell. 2003 Aug;12(2):525-32
references: 14536091
references: Nat Biotechnol. 2001 May;19(5):434-9
references: 11329012
references: Curr Opin Cell Biol. 2005 Jun;17(3):262-8
references: 15901495
references: Oncogene. 2007 Feb 1;26(5):711-24
references: 16862183
references: Oncogene. 2011 Aug 4;30(31):3391-403
references: 21516126
references: Cancer Res. 2006 May 15;66(10):5338-45
references: 16707460
references: Am J Pathol. 2009 May;174(5):1619-28
references: 19349354
references: Adv Exp Med Biol. 2007;623:85-106
references: 18380342